Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gaetano Viscido"'
Publikováno v:
Genome Medicine, Vol 16, Iss 1, Pp 1-20 (2024)
Abstract Background Most primary Triple Negative Breast Cancers (TNBCs) show amplification of the Epidermal Growth Factor Receptor (EGFR) gene, leading to increased protein expression. However, unlike other EGFR-driven cancers, targeting this recepto
Externí odkaz:
https://doaj.org/article/036f678330144a45b4e6b9e53bef263c
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-15 (2023)
Abstract Background Intra-tumour heterogeneity (ITH) presents a significant obstacle in formulating effective treatment strategies in clinical practice. Single-cell RNA sequencing (scRNA-seq) has evolved as a powerful instrument for probing ITH at th
Externí odkaz:
https://doaj.org/article/5619108741b24d43999d6024ad171e4a
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/4a96212e5421441abb5bc6f8619f2e5d
Autor:
Giovanni Marco Nocera, Gaetano Viscido, Stefania Criscuolo, Simona Brillante, Fabrizia Carbone, Leopoldo Staiano, Sabrina Carrella, Diego di Bernardo
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-9 (2022)
VersaLive is a versatile microfluidic platform with flexible input modes and low-volume media reservoirs that can be used for time-lapse live cell imaging, immunostaining, cell recovery, cell lysis and plasmid transfection.
Externí odkaz:
https://doaj.org/article/14824bb56c034c82ab3e20c11dab79c8
Autor:
Giovanni Marco Nocera, Gaetano Viscido, Stefania Criscuolo, Simona Brillante, Fabrizia Carbone, Leopoldo Staiano, Sabrina Carrella, Diego di Bernardo
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/e260660d733c4ecfbe7b24c8cbf05561
Autor:
Valentina Citro, Chiara Cimmaruta, Ludovica Liguori, Gaetano Viscido, Maria Vittoria Cubellis, Giuseppina Andreotti
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0189629 (2017)
The most frequent disorder of glycosylation, PMM2-CDG, is caused by a deficiency of phosphomannomutase activity. In humans two paralogous enzymes exist, both of them require mannose 1,6-bis-phosphate or glucose 1,6-bis-phosphate as activators, but on
Externí odkaz:
https://doaj.org/article/9b610ba074a14368aa953ad37048fe3e
Although many primary triple negative breast cancers (TNBCs) have enhanced expression of epidermal growth factor receptor (EGFR), EGFR-targeted therapies have shown only variable and unpredictable clinical responses in TNBCs. Here we integrate cellul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c3697aee8fc1adfc5a1bd286c7dfef8
https://doi.org/10.1101/2023.04.04.535588
https://doi.org/10.1101/2023.04.04.535588
Publikováno v:
NAR Genomics and Bioinformatics. 5
Although an essential step, the functional annotation of cells often proves particularly challenging in the analysis of single-cell transcriptional data. Several methods have been developed to accomplish this task. However, in most cases, these rely
Autor:
Ludovica Liguori, Maria Vittoria Cubellis, Gaetano Viscido, Chiara Cimmaruta, Valentina Citro, Giuseppina Andreotti
Publikováno v:
PLoS ONE
PloS one 12 (2017). doi:10.1371/journal.pone.0189629
info:cnr-pdr/source/autori:Citro V.; Cimmaruta C.; Liguori L.; Viscido G.; Cubellis M.V.; Andreotti G./titolo:A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG/doi:10.1371%2Fjournal.pone.0189629/rivista:PloS one/anno:2017/pagina_da:/pagina_a:/intervallo_pagine:/volume:12
PLoS ONE, Vol 12, Iss 12, p e0189629 (2017)
PloS one 12 (2017). doi:10.1371/journal.pone.0189629
info:cnr-pdr/source/autori:Citro V.; Cimmaruta C.; Liguori L.; Viscido G.; Cubellis M.V.; Andreotti G./titolo:A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG/doi:10.1371%2Fjournal.pone.0189629/rivista:PloS one/anno:2017/pagina_da:/pagina_a:/intervallo_pagine:/volume:12
PLoS ONE, Vol 12, Iss 12, p e0189629 (2017)
The most frequent disorder of glycosylation, PMM2-CDG, is caused by a deficiency of phosphomannomutase activity. In humans two paralogous enzymes exist, both of them require mannose 1,6-bis-phosphate or glucose 1,6-bis-phosphate as activators, but on